Award notice, first published as presolicitation
Lamotrigine Tablets Jubilant Cadista Pharmaceuticals, Inc. Base Ordering Period 6/16/2025 - 6/15/2026
36E79725R0004
Department of Veterans Affairs, Nac Pharmaceuticals. Pharmaceutical Preparation Manufacturing.
Awarded
Jubilant Cadista Pharmaceuticals Inc.
$0.00 obligated so far on USAspending
Get the next one like this from Department of Veterans Affairs by email, the day it is posted.Find my opportunities
This one was awarded in 2024
9 like it are open now in pharmaceutical preparation manufacturing
- Sacubitril/Valsartan Tablets (VA-27-00014055)
Department of Veterans Affairs, Nac Pharmaceuticals
PresolicitationNAICS 325412Anywhere in the US36E79727R0007Closes in 2 daysNov 3 - Methylphenidate ER
Defense Logistics Agency, DLA Troop Support
SolicitationNAICS 325412Anywhere in the USSPE2D226R0013Closes in 5 daysNov 6 - FY27 Lenalidomide BPA
Department of Veterans Affairs, 262-Network Contract Office 22
Sources soughtNAICS 325412Anywhere in the US36C26227Q0083Closes in 11 daysNov 12
Description
As published on SAM.gov with the solicitation of November 21, 2024.
Amendment for Lamotrigine IR Tablets
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- UEI
- KMQQLKRF5ZE5
- CAGE
- 441M0
- Vendor location
- Yardley, PA
- Contract
- 36E79725D0029
- Obligated
- $0.00, potential $11,913,264
- Actions
- 6 between April 16, 2025 and August 31, 2026
- Competition
- Full and Open Competition, 6 offers received
- Set-aside reported
- No Set Aside Used.
- Described as
- New Award for Lamotrigine Tablets with Jubilant Cadista. Ordering Period Is June 16, 2025 to June 15, 2026 with Four ONE-YEAR Options.
- Match
- award number 36E79725D0029 equals the contract number; same awarding office 36E797 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
October 23, 2024
Presolicitation
Lamotrigine Immediate Release (IR) Tablets
Due November 28, 2024 at 3:30 PM EST. SAM.gov, notice fa6212b357f44d18b8c9923b43a86861
November 5, 2024
Solicitation, originally presolicitation
Lamotrigine Immediate Release (IR) Tablets
Due November 21, 2024 at 3:30 PM EST. SAM.gov, notice 35bb8f0d7fd041e5a1102a469c9cc29b
November 21, 2024
Solicitation
Lamotrigine Immediate Release (IR) Tablets
Due December 3, 2024 at 3:30 PM EST. SAM.gov, notice c3a97acac4cc4815b68c4aedac009bfb
April 16, 2025
Award notice
Awarded to Jubilant Cadista Pharmaceuticals Inc. Yardley 19067 for $11,913,264. SAM.gov, notice de4845942ecd448ea76aa1c4a1b1904c
Points of contact
- Ray Roldan, Contract SpecialistRaymond.Roldan@va.gov708-786-4930